Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma.
Exp Eye Res
; 224: 109221, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36041510
Full text:
1
Database:
MEDLINE
Main subject:
Retinoblastoma
/
Retinal Neoplasms
/
MicroRNAs
Language:
En
Journal:
Exp Eye Res
Year:
2022
Type:
Article